Aspirin rarely used for colorectal cancer prevention

Researchers found that aspirin is rarely used for colorectal cancer prevention, despite evidence showing it can significantly reduce the long-term risk in high-risk groups like those with Lynch syndrome. The CAPP2 study used a high daily dose of 600 milligrams.